bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Direct and High-Throughput Assays for Human Cell Killing through Trogocytosis
by Entamoeba histolytica

Akhila Bettadapur and Katherine S. Ralston

Department of Microbiology and Molecular Genetics, University of
California, Davis.

Please address all correspondence to:
Katherine S. Ralston, Ph.D.
Department of Microbiology and Molecular Genetics
University of California, Davis
1 Shields Avenue
Davis, CA 95616 USA
Tel: +1 (530) 752-5429
Fax: +1 (530) 752-9014
E-mail: ksralston@ucdavis.edu

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1

Abstract

3

disease amoebiasis. Pathogenesis is associated with profound damage to human tissues, and

5

cell-nibbling process that we named trogocytosis (trogo-: nibble). Trogocytosis is likely to

2

Entamoeba histolytica is a microbial eukaryote and causative agent of the diarrheal

4

treatment options are limited. We discovered that amoebae attack and kill human cells through a

6

underlie tissue damage during infection and it represents a potential target for therapeutic

8

trogocytosis by amoebae have not been amenable to studying different types of human cells, or

10

trogocytosis by quantifying human cell viability, both of which can be used for suspension and

12

as a proxy for cell viability. We found that the CellTiterGlo signal is proportional to the quantity

14

We established a second assay that is microscopy-based and uses two fluorescent stains to

16

used with suspension and adherent human cell types, and are amenable to high-throughput

7

intervention, although the mechanism is still unknown. Assays in current use to analyze

9

to high-throughput analysis. Here, we developed two complementary assays to measure

11

adherent cells. The first assay uses CellTiterGlo, a luminescent readout for cellular ATP levels,

13

of viable cells, and can be used to detect death of human cells after co-incubation with amoebae.

15

directly differentiate live and dead human cells. Both assays are simple and inexpensive, can be

17

approaches. These new assays are tools to improve understanding of amoebiasis pathogenesis.

2

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

18

1. Introduction

20

replicating trophozoite (amoeba) form colonizes the large intestine. Symptoms range from

22

name (histo-: tissue; lytic-: dissolve) refers to the capacity of the amoeba to damage human

24

include the amoeba surface galactose and N-acetylgalactosamine (Gal/GalNAc)-inhibitable

19

Entamoeba histolytica is the causative agent of amoebiasis. During infection, the actively

21

asymptomatic infection, diarrhea, bloody diarrhea, to fatal extraintestinal abscesses. The species

23

tissues. However, it is still unclear how amoebae invade and damage tissues. Virulence factors

25

lectin that mediates attachment to human cells and other substrates (Petri, 2002) and cysteine

26

proteases that degrade a variety of human substrates (e.g., Reed, 1995, Lidell, 2006, Thibeaux,

28

histolytica (Ravdin, 1980a, Ravdin, 1981) is likely to be a major contributor to human tissue

27

2012). In addition to these factors, the contact-dependent human-cell killing activity of E.

29

damage.

31

kill human cells was previously unclear (Ralston, 2011). We defined that amoebae kill human

33

physically extract “bites” of human cell membrane, cytoplasm and organelles, which eventually

35

actin rearrangements, PI3K and EhC2PK signaling (Ralston, 2014). Amoebic trogocytosis is

37

(Ralston, 2014). Trogocytosis might be evolutionarily-conserved (Ralston, 2015), therefore,

39

to a better understanding of the pathogenesis of amoebiasis.

30
32

While it has been under investigation for many years, the mechanism by which amoebae

cells via trogocytosis (trogo-: nibble) (Ralston, 2014). Amoebae attach to human cells and then

34

leads to human cell death. Amoebic trogocytosis requires engagement of the Gal/GalNAc lectin,

36

necessary for invasion of ex vivo intestinal tissue, underlining its relevance to pathogenesis

38

studying this process in E. histolytica may give insight into eukaryotic trogocytosis, in addition

3

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

40

In order to better understand trogocytosis and its contribution to disease, there is a need

41

for cell death assays that are accurate, practical and that can be applied to a variety of human cell

43

specifically measure the viability of the human cells when they are mixed together with

45

must be quantitative. While amoebae can kill essentially any human cell type (Ravdin, 1980b),

47

are typically not amenable to the same assays. Thus, there is a need for flexible assays that can

49

important in advancing understanding of cell killing by amoebae, it is important to recognize

42

types. Assaying human cell killing by E. histolytica is inherently challenging since readouts must

44

amoebae. For the greatest utility, assays must directly measure human cell viability, and readouts

46

most studies have focused on either monolayers or suspension cultures, but not both, since they

48

be applied to both monolayers and suspension cells. Although previously used assays have been

50

their limitations and to develop new assays as newer technologies become available.

52

monolayer disruption, and apoptosis assays. Membrane permeabilization assays detect

54

assays, amoebae are co-incubated with human cells, and the supernatant is measured. There are

51

Assays that have been used can be broken down into membrane permeabilization,

53

intracellular components that are released into the culture supernatant by dead cells. In these

55

some technical and practical limitations to the lactate dehydrogenase (LDH) release and

57

2012) generally do not directly measure LDH and instead use the NAD cofactor to catalyze a

59

supernatant that also use NAD as a cofactor can be problematic. By contrast, the 51Cr release

61

51

56

Chromium-51 (51Cr) release assays that have been used. LDH assays (e.g., Li, 1994, Marie,

58

reporter reaction (Riss, 2019). This means that other enzymatic activities in the culture

60

assay specifically measures host cell lysis, since in this assay, host cells are pre-labeled with
Cr, and after incubation with amoebae, 51Cr in the culture supernatant is measured (e.g., Saffer,

4

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

62

1991, Huston, 2001). However, a practical limitation is that this assay requires the use of a

63

radioisotope.

65

that monolayer disruption cannot be directly attributed to cell killing since amoebic cysteine

67

are incubated with host cell monolayers, and after washing, the remaining cells are stained with

69

to control monolayers that were incubated without amoebae, to infer how many cells have been

71

(e.g., Ravdin, 1985, Bracha, 1999). However, since amoebic proteases cause disruption of

64

Monolayer disruption assays have been used in many studies, but the major limitation is

66

protease activity disrupts monolayers (Tillack, 2006). In monolayer disruption assays, amoebae

68

methylene blue (e.g., Bracha, 1984, Teixeira, 2012). The amount of methylene blue is compared

70

released. Trypan blue staining has also been used to stain dead cells remaining in the monolayer

72

monolayers (Tillack, 2006), neither version of this assay directly measures cell killing.

74

Huston, 2001). In these assays, care must be taken to include controls that ensure the readout is

76

besides canonical apoptosis, and thus is not indicative of apoptotic cell death (Kroemer, 2008).

78

with cell permeability stains like propidium iodide, in order to ensure that phosphatidylserine

80

not a universal feature of apoptosis (Galluzzi, 2018). It is also important to note that apoptosis

82

measure cell death after it has occurred. Notably, in some cases, apoptosis can be reversed

73

Finally, apoptosis assays have been used to study cell killing by amoebae (Seydel, 1998,

75

specific to apoptosis. For example, DNA laddering can occur in other modes of cell death

77

As another example, annexin V staining to detect exposed phosphatidylserine must be combined

79

exposure is not simply the result of membrane damage. Notably, phosphatidylserine exposure is

81

assays capture markers of apoptosis in dying cells, which differs from other cell death assays that

83

(Tang, 2012). Thus, cell death is inferred by these assays, but not directly measured.

5

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

84

To enable quantitative cell death measurements, we previously developed an assay using

85

imaging flow cytometry (Ralston, 2014). In this assay, amoebae and human cells are

87

used to stain dead (permeable) cells (Ralston, 2014, Gilmartin, 2017, Miller, 2019). This assay

89

since imaging flow cytometers are not widely available. This assay is more easily applied to

91

flow cytometry is limited in flexibility.

93

we developed two complementary high-throughput assays for human cell death. We show that

95

cell viability. We also develop a confocal microscopy-based assay with fluorescent stains to

97

and they can be used with suspension and adherent human cell types.

86

fluorescently labeled, allowing for trogocytosis to be directly measured, and Live/Dead Violet is

88

allows for automated analysis of thousands of images per sample, but is limited in practicality

90

study suspension cells, since cells must be in suspension during image acquisition; thus, imaging

92

To address the limitations in practicality and flexibility of existing cell death assays, here

94

CellTiterGlo, a luminescent readout for cellular ATP levels, can be used as a proxy for human

96

quantitatively differentiate live and dead human cells. Both assays are simple and inexpensive,

6

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

98
99

100

2. Materials and Methods
2.1 Cell culture
E. histolytica HM1:IMSS (ATCC) trophozoites were cultured in TYI-S-33 media,

101

supplemented with 15% heat inactivated Adult Bovine Serum (Gemini Bio Products), 80

103

40x (Sigma Aldrich), at 35°C. Amoebae were harvested when flasks were approximately 80%

105

L-Glutamine and without Phenol Red (Gibco), supplemented with 10 mM Hepes (Affymetrix),

107

(Gibco), at 37°C with 5% CO2. Cells were harvested at approximately 1x106 cells/mL. Human

102

units/mL penicillin and streptomycin (Gibco), and 2.3% Diamond Vitamin solution 80 Tween

104

confluent. Human Jurkat T cells, clone E6-1 (ATCC), were cultured in RPMI Medium 1640 with

106

100 units/mL penicillin and streptomycin (Gibco) and 10% heat inactivated Fetal Bovine Serum

108

Caco-2 colon epithelial cells, HTB-37 (ATCC), were cultured in MEM Medium (ATCC),

110

passaged using 0.25% (w/v) Trypsin – 0.53 mM EDTA solution when 80-100% confluent.

109

supplemented with 20% Fetal Bovine Serum (Gibco), at 37°C with 5% CO2. Cells were

111

2.2 Knockdown mutants

113

contains 132 base pairs of the trigger gene (EHI_048600) fused to the first 537 base pairs of

115

amoebae using Attractene transfection reagent (Qiagen), and then stable transfectants were

117

limiting dilution, and silencing was confirmed using RT-PCR (Miller, 2019). A single clonal line

112

The EhROM1 silencing construct was generated by Morf, et al. (Morf, 2013), and

114

EhROM1 (EHI_197460). This plasmid, or a corresponding vector control, was transfected into

116

selected and maintained with Geneticin at 6 µg/mL (Invitrogen). Clonal lines were obtained by

118

was used for experiments.

119

2.3 CellTiterGlo Assay

7

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

120

For experiments using Jurkat cells, amoebae and Jurkat cells were first washed in fresh

121

TYI media. For the initial titration experiments (Fig. 1A – 1B), amoebae and Jurkat cells were

123

amoebae were first washed in fresh TYI media and pretreated with 20 nM Cytochalasin D from

125

Cytochalasin D, or DMSO, was maintained at the same concentration when amoebae were

127

resuspended in fresh TYI media with no supplementation, 100 mM galactose (Sigma Aldrich), or

129

S1), amoebae and Jurkat cells were resuspended to 4x105 and 2x106 cells/mL, respectively, to

122

resuspended to 2x106 and 1x107 cells/mL, respectively. For Cytochalasin D experiments,

124

Zygosporium mansonii (Sigma Aldrich) or an equivalent volume of DMSO for 1 hour at 35°C.

126

subsequently co-incubated with Jurkat cells. For sugar inhibition experiments, amoebae were

128

100 mM mannose (Sigma Aldrich). For the initial co-incubation assays (Fig. 1C – 1D and Fig.

130

create a co-incubation ratio of 1 amoeba: 5 Jurkat cells. For all other co-incubation assays,

132

co-incubation ratio of 1:20.

134

individually, with 50 µL of TYI media, or together. Plates were placed in an anerobic GasPak

136

from the incubator and left at 25°C for 10 minutes to equilibrate. 100 µL of CellTiterGlo solution

131
133

amoebae and Jurkat cells were resuspended to 4x105 and 8x106 cells/mL respectively, to create a

50 µL of amoebae or Jurkat cells were plated in 96 well plates (Corning 3603) either

135

(BD) and incubated at 35°C for the appropriate time. At each time point, a plate was removed

137

was added to each well, using a multichannel pipette. Plates were then incubated at 25°C for 10

138

minutes, with rocking, and then luminescence was detected using a 1 second exposure on a plate

140

value per condition, and at least three experiments were performed independently on different

139

reader (PerkinElmer 2030 Victor). Two wells for each condition were averaged to generate one

141

days. Both raw data from individual experiments and normalized data from multiple independent

8

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

142

experiments are presented in the figures. For normalization, data from multiple independent

143

experiments were normalized to the T = 0 time point for each sample.

145

µL of Caco-2 cells were plated in to three 96-well plates (Corning 3603) at a concentration of

147

gently washed with 200 µL of fresh TYI, twice. Amoebae were washed in fresh TYI media and

149

cells to create an approximate co-incubation ratio of 1 amoeba: 10 Caco-2 cells. Plates were

144

For experiments using Caco-2 cells, 18-24 hours prior to performing the experiment, 100

146

2.6x105 cells/mL. On the day of the CellTiterGlo assay, wells containing Caco-2 cells were

148

resuspended to 2.6x104 cells/mL. 100 µL of amoebae were added to wells containing Caco-2

150

incubated and treated with CellTiterGlo as described above. Three wells of amoebae alone, six

152

value per condition, and three experiments were performed independently on different days.

151

wells of Caco-2 cells alone, and six wells of co-incubated samples were averaged to obtain one

153

2.4 Dual-Stain Microscopy Assay

155

treated with 20 nM Cytochalasin D from Zygosporium mansonii (Sigma Aldrich) or an

157

the same concentration when amoebae were subsequently co-incubated with Jurkat cells. Jurkat

159

Amoebae and Jurkat cells were then washed in M199S (Gibco M199 with Earle’s Salts, L-

161

mM L-cysteine (Sigma-Aldrich), 25 mM HEPES (Sigma-Aldrich) and 0.5% bovine serum

163

1x106 cells/mL, respectively in M199S containing 20 nM SYTOX green (Thermo), and 20 nM

154

For experiments using Jurkat cells, amoebae were washed in fresh TYI media and pre-

156

equivalent volume of DMSO for 1 hour at 35°C. Cytochalasin D, or DMSO, was maintained at

158

cells were pre-labeled with Hoechst 33342 (Invitrogen) at 5 µg/ml for 30 minutes at 37°C.

160

Glutamine, 2.2 g/L Sodium Bicarbonate and without Phenol Red, and supplemented with 5.7

162

albumin (Gemini Bio-Products)). Amoebae and Jurkat cells were then resuspended to 2x105 and

164

Cytochalasin D or an equivalent volume of DMSO. 1 mL of each cell type was added to 35 mm

9

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

165

glass bottom petri dishes containing a N° 1.5 coverglass (MatTek). Petri dishes were warmed to

167

microscopy imaging. Cells were imaged using a stage warmer set to 35°C on either an Intelligent

166

35°C for 15 minutes before use. Cells were co-incubated at 35°C for 60 minutes before confocal

168

Imaging Innovations hybrid spinning disk confocal microscope or an Olympus FV1000 laser

170

different days, and 350-500 human cells were counted for each condition.

172

µg/cm2 Collagen I Rat Tail, Gibco) glass bottom petri dishes containing a N° 1.5 coverglass

174

labeled by incubation in 2 mL of M199S containing Hoechst 33342 at 5 µg/ml for 30 minutes at

169
171

point-scanning confocal microscope. Two experiments were performed independently on

For experiments using Caco-2 cells, Caco-2 cells were cultured on collagen-coated (5

173

(MatTek). Experiments were performed when cells were ~80% confluent. Caco-2 cells were pre-

175

37°C. Amoebae and Caco-2 cells were then washed in M199S. Amoebae were resuspended to

177

added to each plate containing Caco-2 cells. Plates were then incubated at 35°C. Cells were

179

microscope.

176

1x105 cells/mL in M199S containing 20 nM SYTOX green, and 2 mL of amoebae were then

178

imaged using a stage warmer set to 35°C on an Olympus FV1000 laser point-scanning confocal

180

2.5 Statistical Analysis

182

unpaired t test statistical analysis. Mean values and standard deviations are shown in the figures,

181

183
184

GraphPad Prism was used to calculate best fit line and R2 values, and for student’s

with t test values reported as follows: ns = P > 0.05, * = P < 0.05, ** = P < 0.01, *** = P <
0.001, **** = P < 0.0001.

185

10

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

186

3. Results

188

cellular ATP levels. We reasoned that since human cells are present in excess of amoebae, they

190

first asked whether luminescence values correlated with the number of amoebae (Fig. 1A) or

192

number. Next, amoebae and Jurkat cells were co-incubated, or as controls, Jurkat human cells or

187

CellTiterGlo is a very simple, high-throughput assay for cell viability that is based on

189

should contribute to the majority of the CellTiterGlo luminescence signal in a co-incubation. We

191

human Jurkat T cells per well (Fig. 1B), and found that luminescence was correlated with cell

193

amoebae were incubated alone. In these controls, the equivalent number of cells were loaded per

195

anticipated, in the controls, the luminescence values were higher for human cells than for

194

well to correspond to the number of cells present in the co-incubation experimental condition. As

196

amoebae (Fig. 1C – 1D). When human cells and amoebae were co-incubated, the luminescence

198

and then decreased over time. The luminescence values of the co-incubation were significantly

197

value initially corresponded to roughly the sum of the human cell and amoeba individual values,

199

lower than the values for human cells incubated alone (Fig. 1D). Reduced variability was

201

aerobic environment (Fig. S1), consistent with the microaerophilic metabolism of E. histolytica.

203

using CellTiterGlo.

205

killing by amoebae. Trogocytosis by E. histolytica requires actin rearrangements and is inhibited

207

control-treated amoebae were co-incubated with Jurkat cells, and cell viability was measured

200

observed when samples were incubated in an anaerobic GasPak (Fig. 1C – 1D), compared to an

202

Therefore, we concluded that human cell killing by amoebae can be quantitatively measured

204

We next asked whether this assay was sensitive to conditions that inhibit human cell

206
208

by treatment with cytochalasin D (Ralston, 2014). Therefore, cytochalasin D-treated or DMSO

using CellTiterGlo (Fig. 2A – 2B). Cytochalasin D-treated amoebae were significantly less able

11

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

209

to kill human cells, as seen by the increased CellTiterGlo signal compared to control amoebae

210

(Fig. 2A – 2B). For human cells or amoebae incubated alone, cytochalasin D treatment did not

212

amoeba surface Gal/GalNAc lectin. Amoeba must attach to human cells in order to kill them,

214

amoebae were significantly less able to kill human cells, compared to control mannose-treated

216

protease, EhRom1, which has a characterized role in attachment to human cells (Baxt, 2008,

218

knockdown mutants and vector control amoebae (Fig. 2D, S2C). This is consistent with the lack

211

affect viability (Fig. S2A). We next tested if CellTiterGlo was sensitive to inhibition of the

213

and this attachment is mediated by the amoebic GalNAc lectin (Petri, 2002). Galactose-treated

215

amoebae (Fig. 2C, S2B). Finally, we tested knockdown mutant amoebae deficient in a rhomboid

217

Baxt, 2010). There was no significant difference in the cell killing ability between EhRom1

219

of a trogocytosis defect in EhRom1 mutants (Miller, 2019). Taken together, we concluded that

220

the CellTiterGlo assay is sensitive to the inhibition of human cell killing by amoebae.

222

killing are difficult to adapt to both suspension and monolayer cells. Therefore, we adapted the

221

We next sought to extend this assay to other human cell types, since many assays for cell

223

CellTiterGlo assay to human Caco-2 intestinal epithelial cell monolayers. CellTiterGlo

225

(Fig. 3A – 3B). When Caco-2 cells and amoebae were co-incubated, the luminescence value

227

3C). The luminescence values of the co-incubation were significantly lower than the values for

229

assay killing of both suspension and monolayer cells.

231

amoebae. Since human cell nuclei are not internalized during amoebic trogocytosis (Ralston,

224

luminescence values correlated closely with the number of amoebae or Caco-2 cells per well

226

initially corresponded to roughly the sum of the human cell and amoeba individual values (Fig.

228

human cells incubated alone (Fig. 3D). These results show that CellTiterGlo can be applied to

230

We next developed a microscopy-based assay to directly measure human cell killing by

12

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

232

2014), we devised a strategy with two different nuclear stains to distinguish living and dead

234

green was present in the media. SYTOX green is a nucleic acid stain that is excluded by living

236

cells are labeled only by Hoechst, while dead human cells are dual-labeled by both Hoechst and

233

human cells. Human cell nuclei were pre-labeled with Hoechst. During co-incubation, SYTOX

235

cells, but is taken up by dead cells because they have permeable membranes. Thus, live human

237

SYTOX green (Supplemental Video 1). To test this dual-stain assay, cytochalasin D treatment

238

was used to inhibit amoebic trogocytosis. Amoebae were treated with cytochalasin D or DMSO,

240

less than 2% of Jurkat cells in 60 minutes (Fig. 4B). By comparison, control amoebae killed 40%

242

robust enough to be amenable to imaging large fields of cells at low magnification (Fig. 4C).

244

Videos 2 – 3), demonstrating that it is versatile with respect to human cell types.

239

and co-incubated with human Jurkat T cells (Fig. 4A). Cytochalasin D-treated amoebae killed

241

of Jurkat cells in 60 minutes. This assay provides a quantitative readout for cell killing, and it is

243

Finally, this dual-stain assay can be applied to Caco-2 epithelial cells (Fig. 5 and Supplemental

245

13

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

246

4. Discussion

248

CellTiterGlo assay biochemically measures cellular ATP levels, and the dual-stain microscopy

250

complement the currently available cell death assays and bring their own unique strengths and

247

In this study, we developed two assays for human cell killing by E. histolytica. The

249

assay allows for direct visualization of human cell death with fluorescent stains. These assays

251

weaknesses.

253

readout. The assay requires few manipulations and no washing steps; CellTiterGlo solution is

255

Since this assay is robust and requires very few steps, the procedure is amenable to high

257

for drugs that kill E. histolytica (Debnath, 2012). The limitation of this assay is that it does not

259

assay, they contribute the majority of the ATP to the readout, and thus, a decrease in

261

apoptosis assays, ATP levels are correlated with dying cells, but do not clearly define the “point

263

ATP below a threshold, combined with redox alterations, has been proposed to mark the “point

265

CellTiterGlo that the level of ATP has definitively crossed a threshold. However, the major

267

an area where none of the existing cell death assays are useful. Thus, we propose that this assay

252

The CellTiterGlo assay is simple and practical. Only a plate reader is required for the

254

added directly to cells, and after a brief incubation, luminescence is measured on a plate reader.

256

throughput screening. Indeed, CellTiterGlo has previously been used in a high throughput screen

258

directly measure human cell death. Because human cells greatly outnumber amoebae in this

260

luminescence can be inferred to represent human cell death. Also, similar to the limitations of

262

of no return” when a cell is by definition, dead (Leist, 1997, Bonora, 2012). The depletion of

264

of no return” (Galluzzi, 2015), however, it would be difficult to infer from an assay like

266

strengths of this assay are the simplicity and adaptability to high throughput approaches. This is

268

is most useful for initial screening of mutants or candidate inhibitors. Finally, since monolayers

14

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

269

can be grown directly in the plates used for this assay, it is easily adaptable to both monolayers

271

The dual-stain microscopy-based cell death assay is also simple and practical. We used

270

and suspension cells.

272

confocal microscopy for imaging, but this is not necessary, as widefield fluorescence

274

cell death. Dead cells are labeled, thus human cell death can be directly quantified within a

276

membrane integrity, which is a direct marker of cells that are dead (Kroemer, 2008). Thus, this

273

microscopes can also be used. The major strength of this assay is that it directly measures human

275

mixture of human cells and amoebae. Moreover, the readout for cell death in this assay is loss of

277

assay, together with the imaging flow cytometry assay that we developed (Ralston, 2014),

279

stain assay is more practical and easy to apply, since imaging flow cytometers are not widely

281

throughput approaches, as it could be performed by using cells in plates and by imaging on high

283

quantitative, and requires counting of labeled cell nuclei. We did not develop automated image

285

Because both stains label the same cellular feature, the nucleus, automated image analysis should

287

amenable to both monolayer and suspension cell cultures.

289

killing by E. histolytica. They are particularly simple and practical, and thus we believe they are

291

cell killing by E. histolytica is likely to underlie disease pathogenesis, these tools are expected to

278

represents the most direct assays available for human cell killing for E. histolytica. The dual-

280

available. Like imaging flow cytometry, the dual-stain assay can be applied to medium

282

content screening microscopes. The limitation of this assay is that the readout is not inherently

284

analysis, but this would be possible, and would ensure that the readout is unbiased and efficient.

286

be particularly robust. Finally, like the CellTiterGlo assay, the dual-stain microscopy assay is

288
290

Together, these assays expand the repertoire of available tools for studying human cell

suitable for wide application. These assays also pave the way for high-throughput studies. Since

15

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

292
293

allow for an improved understanding of the mechanism of disease, and may be applicable to the
development of new therapeutics.

16

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

294

Acknowledgments

296

microscopes and technical assistance. We thank the Ralston lab for stimulating discussions and

298

to K.S.R., and the UC Davis Biotechnology Training Program fellowship awarded to A.B.

295

We thank the MCB Microscopy Imaging Facility at UC Davis for use of core

297

support. This work was supported by NIH grant 1R01AI146914 and a Pew Scholarship awarded

299

Declaration of interest: none.

17

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

300

References

302

protease with atypical specificity cleaves a surface lectin involved in phagocytosis and

301

Baxt, L. A., Baker, R. P., Singh, U. and Urban, S. (2008). "An Entamoeba histolytica rhomboid

303

immune evasion." Genes Dev 22(12): 1636-1646.

304
305
306
307
308
309
310
311

312

Baxt, L. A., Rastew, E., Bracha, R., Mirelman, D. and Singh, U. (2010). "Downregulation of an

Entamoeba histolytica rhomboid protease reveals roles in regulating parasite adhesion and
phagocytosis." Eukaryot Cell 9(8): 1283-1293.

Bonora, M., Patergnani, S., Rimessi, A., De Marchi, E., Suski, J. M., Bononi, A., Giorgi, C.,

Marchi, S., Missiroli, S., Poletti, F., Wieckowski, M. R. and Pinton, P. (2012). "ATP synthesis
and storage." Purinergic Signal 8(3): 343-357.

Bracha, R. and Mirelman, D. (1984). "Virulence of Entamoeba histolytica trophozoites." J.
Exp. Med 160: 353-368.

Bracha, R., Nuchamowitz, Y., Leippe, M. and Mirelman, D. (1999). "Antisense inhibition of

313

amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence."

315

Debnath, A., Parsonage, D., Andrade, R. M., He, C., Cobo, E. R., Hirata, K., Chen, S., García-

314

316
317

318

Molecular Microbiology 34(3): 463-472.

Rivera, G., Orozco, E., Martínez, M. B., Gunatilleke, S. S., Barrios, A. M., Arkin, M. R., Poole, L.
B., McKerrow, J. H. and Reed, S. L. (2012). "A high-throughput drug screen for Entamoeba
histolytica identifies a new lead and target." Nature Med 18(6): 956-960.

319

Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D.,

321

N. G., Bertrand, M. J., Bianchi, K., Blagosklonny, M. V., Blomgren, K., Borner, C., Bredesen, D.

320
322

Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., Baehrecke, E. H., Bazan,

E., Brenner, C., Campanella, M., Candi, E., Cecconi, F., Chan, F. K., Chandel, N. S., Cheng, E. H.,
18

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

323

Chipuk, J. E., Cidlowski, J. A., Ciechanover, A., Dawson, T. M., Dawson, V. L., De Laurenzi, V.,

325

G. M., Flavell, R. A., Fulda, S., Garrido, C., Gougeon, M. L., Green, D. R., Gronemeyer, H.,

327

T., Kepp, O., Klionsky, D. J., Knight, R. A., Kumar, S., Lemasters, J. J., Levine, B., Linkermann,

324
326
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343

344
345

De Maria, R., Debatin, K. M., Di Daniele, N., Dixit, V. M., Dynlacht, B. D., El-Deiry, W. S., Fimia,

Hajnoczky, G., Hardwick, J. M., Hengartner, M. O., Ichijo, H., Joseph, B., Jost, P. J., Kaufmann,
A., Lipton, S. A., Lockshin, R. A., Lopez-Otin, C., Lugli, E., Madeo, F., Malorni, W., Marine, J. C.,
Martin, S. J., Martinou, J. C., Medema, J. P., Meier, P., Melino, S., Mizushima, N., Moll, U.,
Munoz-Pinedo, C., Nunez, G., Oberst, A., Panaretakis, T., Penninger, J. M., Peter, M. E.,

Piacentini, M., Pinton, P., Prehn, J. H., Puthalakath, H., Rabinovich, G. A., Ravichandran, K. S.,
Rizzuto, R., Rodrigues, C. M., Rubinsztein, D. C., Rudel, T., Shi, Y., Simon, H. U., Stockwell, B.

R., Szabadkai, G., Tait, S. W., Tang, H. L., Tavernarakis, N., Tsujimoto, Y., Vanden Berghe, T.,
Vandenabeele, P., Villunger, A., Wagner, E. F., Walczak, H., White, E., Wood, W. G., Yuan, J.,

Zakeri, Z., Zhivotovsky, B., Melino, G. and Kroemer, G. (2015). "Essential versus accessory

aspects of cell death: recommendations of the NCCD 2015." Cell Death Differ 22(1): 58-73.

Galluzzi, L., Vitale, I., Aaronson, S., Abrams, J., Adam, D., Agostinis, P., Alnemri, E., Altucci, L.,

Amelio, I., Andrews, D., Annicchiarico-Petruzzelli, M, , Antonov, A., Arama, E., Baehrecke, E.,
Barlev, N., Bazan, N., Bernassola, F., Bertrand, M., Bianchi, K., Blagosklonny, MV, Blomgren,
K, , Borner, C., Boya, P., Brenner, C., Campanella, M., Candi, E., Carmona-Gutierrez, D.,

Ceccon, i. F., Chan, F., Chandel, N., Cheng, E., Chipuk, J., Cidlowski, J., Ciechanover, A, , Cohen,
G., Conrad, M., Cubillos-Ruiz, J., Czabotar, PE, D'Angiolella, V, , Dawson, T., Dawson, V., De
Laurenzi, V., De Maria, R., Debatin, K., DeBerardinis, RJ, Deshmukh, M, , Di Daniele, N., Di

Virgilio, F., Dixit, V., Dixon, S., Duckett, C., Dynlacht, B., El-Deiry, W., Elrod, J., Fimia, G., Fulda,
S., García-Sáez, A., Garg, A., Garrido, C., Gavathiotis, E., Golstein, P., Gottlieb, E., Green, D.,

19

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

346

Greene, L., Gronemeyer, H, , Gross, A., Hajnoczky, G., Hardwick, J., Harris, I., Hengartner, M.,

348

Kepp, O., Kimchi, A., Kitsis, R., Klionsky, D., Knight, R., Kumar, S., Lee, S., Lemasters, J.,

347
349
350
351
352
353
354
355
356
357
358
359
360

361

Hetz, C., Ichijo, H., Jäättelä, M., Joseph, B., Jost, P., Juin, P., Kaiser, W., Karin, M., Kaufmann, T.,
Levine, B., Linkermann, A., Lipton, S., Lockshin, R., López-Otín, C., Lowe, S., Luedde, T., Lugli,
E., MacFarlane, M., Madeo, F., Malewicz, M., Malorni, W., Manic, G., Marine, J., Martin, S.,
Martinou, J., Medema, J., Mehlen, P., Meier, P., Melino, S., Miao, E., Molkentin, J., Moll, U.,

Muñoz-Pinedo, C., Nagata, S., Nuñez, G., Oberst, A., Oren, M., Overholtzer, M., Pagano, M.,

Panaretakis, T., Pasparakis, M., Penninger, J., Pereira, D., Pervaiz, S., Peter, M., Piacentini, M.,
Pinton, P., Prehn, J., Puthalakath, H., Rabinovich, G., Rehm, M., Rizzuto, R., Rodrigues, C.,

Rubinsztein, D., Rudel, T., Ryan , K., Sayan, E., Scorrano, L., Shao, F., Shi, Y., Silke, J., Simon, H.,
Sistigu, A., Stockwell, B., Strasser, A., Szabadkai, G., Tait, S., Tang, D., Tavernarakis, N.,

Thorburn, A., Tsujimoto, Y., Turk, B., Vanden Berghe, T., Vandenabeele, P., Vander Heiden,

M., Villunger, A., Virgin, H., Vousden, K., Vucic, D., Wagner, E., Walczak, H., Wallach, D., Wang,
Y., Wells, J., Wood, W., Yuan, J., Zakeri, Z., Zhivotovsky, B., Zitvogel, L., Melino , G. and
Kroemer, G. (2018). "Molecular mechanisms of cell death: recommendations of the
Nomenclature Committee on Cell Death 2018." Cell Death Differ 25(3): 486-541.

362

Gilmartin, A., Ralston, K. and Petri, W. J. (2017). "Inhibition of Amebic Lysosomal

364

Huston, C. D., Houpt, E. R., Mann, B. J., Hahn, C. S. and Petri, W. A., Jr. (2001). "Caspase 3‐

366

Microbiology 2(6).

363

365
367
368

Acidification Blocks Amebic Trogocytosis and Cell Killing." mBio 8(4).

dependent killing of host cells by the parasite Entamoeba histolytica." Cellular

Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H.,

Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., Hengartner, M., Knight, R. A.,

20

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

369

Kumar, S., Lipton, S. A., Malorni, W., Nuñez, G., Peter, M. E., Tschopp, J., Yuan, J., Piacentini,

371

the Nomenclature Committee on Cell Death 2009." Cell Death & Differentiation 16(1): 3-11.

370
372
373

374

M., Zhivotovsky, B. and Melino, G. (2008). "Classification of cell death: recommendations of
Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. and Nicotera, P. (1997). "Intracellular

Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis
and Necrosis." Journal of Experimental Medicine 185(8).

375

Li, E., Stenson, W. F., Kunz-Jenkins, C., Swanson, P. E., Duncan, R. and Stanley, S. L. J. (1994).

377

Cells." Infection and Immunity 62(11): 5112-5119.

379

cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the

376
378

380
381
382
383
384
385
386
387
388

389

"Entamoeba histolytica Interactions with Polarized Human Intestinal Caco-2 Epithelial

Lidell, M. E., Moncada, D. M., Chadee, K. and Hansson, G. C. (2006). "Entamoeba histolytica
protective colonic mucus gel." Proc Natl Acad Sci U S A 103(24): 9298-9303.

Marie, C. S., Verkerke, H. P., Paul, S. N., Mackey, A. J., Petri, W. A. Jr. (2012). " Leptin protects
host cells from Entamoeba histolytica cytotoxicity by a STAT3-dependent mechanism. ."
Infect Immun 80(5): 1934-1943.

Miller, H. W., Suleiman, R. L. and Ralston, K. S. (2019). "Trogocytosis by Entamoeba

histolytica Mediates Acquisition and Display of Human Cell Membrane Proteins and
Evasion of Lysis by Human Serum." mBio 10(2).

Morf, L., Pearson, R. J., Wang, A. S. and Singh, U. (2013). "Robust gene silencing mediated by
antisense small RNAs in the pathogenic protist Entamoeba histolytica." Nucleic Acids
Research 41(20): 9424-9437.

21

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

390

Petri, W. A., Jr., Haque, R. and Mann, B. J. (2002). "The bittersweet interface of parasite and

392

histolytica." Annu Rev Microbiol 56: 39-64.

391

393
394
395

396
397

398

399
400
401
402
403
404
405
406
407
408
409
410
411
412

host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba
Ralston, K. S. (2015). "Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and
beyond." Curr Opin Microbiol 28: 26-35.

Ralston, K. S. and Petri, W. A., Jr (2011). "Tissue destruction and invasion by Entamoeba
histolytica." Trends Parasitol 27(6): 254-263.

Ralston, K. S., Solga, M. D., Mackey-Lawrence, N. M., Somlata, Bhattacharya, A. and Petri, W.
A., Jr. (2014). "Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue
invasion." Nature 508(7497): 526-530.

Ravdin, J. I., Croft, B. Y. and Guerrant, R. L. (1980). "Cytopathogenic mechanisms of
Entamoeba histolytica." J Exp Med 152(2): 377-390. (a)

Ravdin, J. I. and Guerrant, R. L. (1980). "Studies on the cytopathogenicity of Entamoeba
histolytica." Arch. Invest. Med. (Mex) 11: 123-128. (b)

Ravdin, J. I. and Guerrant, R. L. (1981). "Role of adherence in cytopathogenic mechanisms of
Entamoeba histolytica. Study with mammalian tissue culture cells and human
erythrocytes." J Clin Invest 68(5): 1305-1313.

Ravdin, J. I., Murphy, C. F., Guerrant, R. L. and Long-Krug, S. A. (1985). "Effect of Antagonists
of Calcium and Phospholipase A on the Cytopathogenicity of Entamoeba histolytica." The
Journal of Infectious Diseases 152(3): 542–549.

Reed, S., Ember, J., Herdman, D., DiScipio, R., Hugli, T. and Gigli, I. (1995). "The extracellular
neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and
C5a." J Immunol 155(1): 266-274.

22

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

413

Riss, T. and Niles, A., Moravec, R, Karassina, N, Vidugiriene, J (2019). Cytotoxicity Assays: In

415

Center for Advancing Translational Sciences.

414

Vitro Methods to Measure Dead Cells. Bethesda (MD), Eli Lilly & Company and the National

416

Saffer, L. D. and Petri, W. A. (1991). "Role of the galactose lectin of Entamoeba histolytica in

418

4683.

420

liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway

417

419

adherence-dependent killing of mammalian cells." Infection and Immunity 59(12): 4681-

Seydel, K. and Stanley, S. J. (1998). "Entamoeba histolytica induces host cell death in amebic

421

of apoptosis." Infect Immun. 66(6): 2980-2983.

423

Talbot, C. J., Lau, W., Montell, D. and Fung, M. (2012). "Cell survival, DNA damage, and

422
424

425

Tang, H., Tang, H., Mak, K., Hu, S., Wang, S., Wong, K., Wong, C., Wu, H., Law, H., Liu, K.,

oncogenic transformation after a transient and reversible apoptotic response." Mol Biol
Cell 23(12): 2240-2252.

426

Teixeira, J. E., Sateriale, A., Bessoff, K. E. and Huston, C. D. (2012). "Control of Entamoeba

428

Metalloprotease with Homology to Leishmanolysin." Infect Immun 80(6): 2165–2176.

427
429
430

431

histolytica Adherence Involves Metallosurface Protease 1, an M8 Family Surface

Thibeaux, R., Dufour, A., Roux, P., Bernier, M., Baglin, A. C., Frileux, P., Olivo-Marin, J. C.,

Guillen, N. and Labruyere, E. (2012). "Newly visualized fibrillar collagen scaffolds dictate

Entamoeba histolytica invasion route in the human colon." Cell Microbiol 14(5): 609-621.

432

Tillack, M., Nowak, N., Lotter, H., Bracha, R., Mirelman, D., Tannich, E. and Bruchhaus, I.

434

transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba

433
435

(2006). "Increased expression of the major cysteine proteinases by stable episomal
histolytica." Molecular and Biochemical Parasitology 149(1): 58-64.

23

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

436

Figure legends

437

Figure 1: CellTiterGlo can be used to assay Jurkat cell killing by amoebae. (A) A dilution

439

R2 values are shown. CellTiterGlo signal correlates with the number of cells per well. Data

438

series of amoebae, or (B) human Jurkat T cells was assayed using CellTiterGlo. Best fit lines and

440

represent the average values of two replicate wells for each cell concentration, and are

442

with Jurkat cells at a 1:5 ratio, or amoebae (filled triangles) and Jurkat cells (filled squares) were

444

each sample, from one experiment. (D) Data from 2 independent experiments performed as in

446

significant differences between the co-incubation and Jurkat alone samples, as indicated.

448

Figure 2: CellTiterGlo can be used to assay trogocytosis inhibition and attachment

450

symbols) or DMSO (filled symbols). Amoebae were co-incubated (circles) with Jurkat cells at a

441

representative of 3 independent experiments. (C) Amoebae were co-incubated (filled circles)

443

incubated separately as controls. Data represent the average values of two replicate wells for

445

Panel C were normalized to the value of each sample at Time = 0. There were statistically

447
449

inhibition. (A) Amoebae and human Jurkat T cells were treated with Cytochalasin D (open

451

1:20 ratio, or amoebae (triangles) and Jurkat cells (squares) were incubated separately as

453

replicate wells for each sample, from one experiment. (B) Data from 4 independent experiments

455

and Jurkat cells were incubated in media containing galactose, mannose, or no added sugar. Cells

457

using CellTiterGlo. Data from 3 independent experiments were normalized to the value of each

452

controls. Viability was assayed by using CellTiterGlo. Data represent the average values of two

454

performed as in panel A were normalized to the value of each sample at Time = 0. (C) Amoebae

456

were co-incubated at a 1:20 ratio, or incubated separately as controls. Viability was assayed by

458

sample at Time = 0. (D) Amoebae were transfected with an EhRom1 knockdown plasmid, or a

24

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

459

vector control plasmid. Transfectants, or wild-type non-transfected amoebae, were co-incubated

461

experiments were normalized to the value of each sample at Time = 0.

463

Figure 3: CellTiterGlo can be used to assay Caco-2 cell killing by amoebae. (A) A dilution

460
462

464

with Jurkat cells at a 1:20 ratio, or incubated separately as controls. Data from 3 independent

series of amoebae, or (B) human Caco-2 intestinal epithelial cells was assayed using

465

CellTiterGlo. Best fit lines and R2 values are shown. CellTiterGlo signal correlates with the

467

concentration, and are representative of 3 independent experiments. (C) Amoebae were co-

469

squares) were incubated separately as controls. Data represent the average values of two replicate

471

performed as in panel C were normalized to the value of each sample at Time = 0. There were

466

number of cells per well. Data represent the average values of two replicate wells for each cell

468

incubated (filled circles) with Caco-2 cells, or amoebae (filled triangles) and Caco-2 cells (filled

470

wells for each sample, from one experiment. (D) Data from 3 independent experiments

472

statistically significant differences between the co-incubation and Caco-2 alone samples, as

473

indicated.

474
475

Figure 4: A dual-stain microscopy assay can be used to quantitatively and directly detect

477

treated with Cytochalasin D or DMSO, and co-incubated for 60 minutes in the presence of

479

(blue), while dead human cells are labeled by both Hoechst and SYTOX green (green) and

481

(arrowhead) are indicated. Scale bar, 50 µm. (B) Human cell death was assayed by quantifying

476

Jurkat cell killing by amoebae. (A) Amoebae and Hoechst-labeled human Jurkat T cells were

478

SYTOX green. Representative images are shown. Living human cells are labeled by Hoechst

480

appear as turquoise in the merged image. An example of a living cell (arrow) and a dead cell

25

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

482

the number of single-stained (Hoechst) and dual-stained (Hoescht and SYTOX green) human

484

representative of 2 independent experiments. (C) Representative images demonstrating that the

486

cells to be imaged per field. Scale bar, 50 µm.

488

Figure 5: A dual-stain microscopy assay can be used to directly detect Caco-2 cell killing by

490

incubated in the presence of SYTOX green. Living human cells are labeled by Hoechst (blue),

483

cell nuclei, which correspond to living and dead human cells, respectively. Data are

485

dual-stain assay can be applied to low magnification objectives, allowing for a greater number of

487

489

amoebae. Amoebae and Hoechst-labeled human Caco-2 intestinal epithelial cells were co-

491

while dead human cells are labeled by both Hoechst and SYTOX green (green) and appear as

493

living and labeled only by Hoechst, but is eventually killed by an amoeba, at which time it

492

494

495

turquoise in the merged image. The arrow indicates an example of a Caco-2 cell that is initially

becomes labeled by SYTOX green (arrowhead). Data are representative of 2 independent
experiments. Scale bar, 50 µm.

26

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

496

Supplemental Figure 1: Greater variability is observed in the CellTiterGlo assay when cells

498

with Jurkat cells at a 1:5 ratio, or amoebae (filled triangles) and Jurkat cells (filled squares) were

500

each sample, from one experiment. (B) Data from 2 independent experiments performed as in

502

significant differences between the co-incubation and Jurkat cell samples, as indicated.

504

Supplemental Figure 2: Additional controls for the CellTiterGlo assay data shown in

506

and viability was assayed using CellTiterGlo. Data from 4 independent experiments were

508

incubated in media containing galactose, mannose, or no added sugar, and viability was assayed

510

sample at Time = 0. (C) Amoebae were transfected with an EhRom1 knockdown plasmid, or a

512

Jurkat cells was assayed using CellTiterGlo. Data from 3 independent experiments were

497

are incubated without an anaerobic GasPak. (A) Amoebae were co-incubated (filled circles)

499

incubated separately as controls. Data represent the average values of two replicate wells for

501

Panel A were normalized to the value of each sample at Time = 0. There were statistically

503
505

Figure 2. (A) Amoebae and human Jurkat T cells were treated with Cytochalasin D or DMSO

507

normalized to the value of each sample at Time = 0. (B) Amoebae and Jurkat cells were

509

using CellTiterGlo. Data from 3 independent experiments were normalized to the value of each

511

vector control plasmid. The viability of transfectants, wild-type non-transfected amoebae, and

513

normalized to the value of each sample at Time = 0.

27

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

514

Supplemental Video 1: A dual-stain microscopy assay directly detects Jurkat cell killing by

515

amoebae. Amoebae and Hoechst-labeled human Jurkat T cells were co-incubated in the

517

frames/minute. Living human cells are labeled by Hoechst (blue), while dead human cells are

519

Data are representative of 2 independent experiments.

521

Supplemental Videos 2 and 3: A dual-stain microscopy assay directly detects Caco-2 cell

523

were co-incubated in the presence of SYTOX green. Representative videos are shown. Videos

525

human cells are labeled by Hoechst (blue), while dead human cells are labeled by both Hoechst

516

518

520

presence of SYTOX green. A representative video is shown, covering 20 minutes, captured at 2

labeled by both Hoechst and SYTOX green (green) and appear as turquoise in the merged video.

522

killing by amoebae. Amoebae and Hoechst-labeled human Caco-2 intestinal epithelial cells

524

each follow the same field of cells and cover 20 minutes, captured at 1 frame/minute. Living

526

and SYTOX green (green) and appear as turquoise in the merged video. Data are representative

527

of 2 independent experiments.

528

28

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

529

Figure 1

A

B

A m o e b a e a lo n e

80000

0.9743

60000

R square
L u m in e s e n c e

L u m in e s e n c e

J u r k a t h u m a n c e lls a lo n e

200000

R square

40000

20000

100000

50000

0

0

0

10000

20000

0

30000

200000

J u r k a t h u m a n c e lls a lo n e

C
80000

400000

600000

C e ll c o n c e n t r a tio n

C e ll c o n c e n t r a tio n

J u r k a t h u m a n c e lls a lo n e

D

C o -in c u b a tio n

C o -in c u b a tio n

N o r m a liz e d lu m in e s c e n e

2 .0

A m o e b a e a lo n e
L u m in e s e n c e

0.9726

150000

60000

40000

20000

0

*

A m o e b a e a lo n e
1 .5

**
1 .0

**

0 .5

0 .0
0

20

40

60

T im e ( m in u te s )

80

100

0

20

40

60

80

100

T im e ( m in u te s )

29

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

Figure 2

A

B

1 .5

N o r m a liz e d lu m in e s c e n e

250000

200000

L u m in e s e n c e

150000

100000

50000

0 .5

0 .0

0

20

40

60

80

**

1 .0

0

D M S O C y to D

D M S O C y to D

D M S O C y to D

0 m in

4 5 m in

9 0 m in

100

C o - in c u b a t io n

T im e ( m in u te s )
J u r k a t h u m a n c e lls a lo n e D M S O
J u r k a t h u m a n c e lls a lo n e C y to D

C o - in c u b a t io n D M S O
C o - in c u b a t io n C y t o D
A m o e b a e a lo n e D M S O

A m o e b a e a lo n e C y to D

C

D

1 .5

1 .5

N o r m a liz e d lu m in e s c e n e

N o r m a liz e d lu m in e s c e n e

530

**
1 .0

0 .5

0 .0
T im e ( m in u te s )

0

45

90

N o t r e a tm e n t

0

45

90

G a la c t o s e

0

45

90

M annose

1 .0

0 .5

0 .0
T im e ( m in u te s )
Am oebae

C o - in c u b a t io n

0

45
WT

90

0

45

90

V e c to r

0

45

90

ROM1

C o - in c u b a t io n

30

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

531

Figure 3

C a c o -2 h u m a n c e lls a lo n e

A

25000

R s q u a re | 0 .9 8 0 2

R s q u a re | 0 .9 9 5 8

20000

60000

L u m in e s e n c e

L u m in e s e n c e

80000

A m o e b a e a lo n e

B

40000

20000

15000

10000

5000
0

0
0

20000

40000

60000

0

2000

C e ll c o n c e n t r a tio n

C

6000

D
C a c o -2 h u m a n c e lls a lo n e

150000

N o r m a liz e d lu m in e s c e n e

A m o e b a e a lo n e
100000

50000

0

0

20

40

C a c o -2 h u m a n c e lls a lo n e

1 .5

C o -in c u b a tio n

L u m in e s e n c e

4000

C e ll c o n c e n t r a tio n

60

T im e ( m in u t e s )

80

100

C o -in c u b a tio n
A m o e b a e a lo n e

***

1 .0

0 .5

0 .0
0

20

40

60

80

100

T im e (m in u te s )

31

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

532

Figure 4
A

D IC

H oescht

SYTO X

( a ll J u r k a t n u c le i)

( d e a d J u r k a t n u c le i)

M e rg e

D M S O c o n tr o l
A m o e b a e + J u rk a t
h u m a n c e lls

C y to D tre a te d
A m o e b a e + J u rk a t
h u m a n c e lls

B

% h u m a n c e ll d e a th

50

***
40

30

20

10

0
D M S O c o n tr o l

C

C y to D tre a te d

Am oebae

Am oebae

+ J u rk a t h u m a n

+ J u rk a t h u m a n

c e lls

c e lls

H oescht

SYTO X

( a ll h u m a n c e ll n u c le i)

( d e a d h u m a n c e ll n u c le i)

M e rg e

32

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

533

Figure 5

DIC

Hoechst

SYTOX

(all Caco-2 nuclei) (dead Caco-2 nuclei)

Merge

1 min

10 min

20 min

30 min

40 min

33

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

534

Supplemental Figure 1

J u r k a t h u m a n c e lls a lo n e

A

C o -in c u b a tio n

80000

L u m in e s e n c e

A m o e b a e a lo n e
60000

40000

20000

0

0

20

40

60

80

100

80

100

T im e ( m in u te s )

B
J u r k a t h u m a n c e lls a lo n e
N o r m a liz e d lu m in e s c e n e

2 .0

C o -in c u b a tio n
A m o e b a e a lo n e
1 .5

*
1 .0

0 .5

0 .0
0

20

40

60

T im e ( m in u te s )

34

bioRxiv preprint doi: https://doi.org/10.1101/768069; this version posted September 18, 2019. The copyright holder for this preprint (which was
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

A

N o r m a liz e d lu m in e s c e n e

1 .5

Supplemental Figure 2

B

1 .5

N o r m a liz e d lu m in e s c e n e

535

1 .0

0 .5

1 .0

0 .5

0 .0

0 .0
T im e (m in u te s )

0 45 90
DMSO

0 45 90
C y to D

J u r k a t h u m a n c e lls a lo n e

0 45 90
0 45 90
DMSO
C y to D
A m o e b a e a lo n e

T im e ( m in u te s ) 0 4 5 9 0 0 4 5 9 0 0 4 5 9 0 0 4 5 9 0 0 4 5 9 0 0 4 5 9 0
M an
M an
G al
T re a tm e n t
G al
A m o e b a e a lo n e

J u r k a t h u m a n c e lls a lo n e

N o r m a liz e d lu m in e s c e n e

C
2 .0

1 .5

1 .0

0 .5

0 .0
T im e ( m in u te s )
Am oebae

0 45 90
-

0 45 90
WT

0 45 90
V e c to r

Ju rk a t h u m a n

Am oebae

c e lls a lo n e

a lo n e

0 45 90
ROM1

35

